David M. Lang
YOU?
Author Swipe
View article: Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis
Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis Open
Among individuals with chronic urticaria refractory to antihistamines, standard-dose omalizumab and remibrutinib are among the most effective drugs across multiple patient-important outcomes with a favorable safety profile across the studi…
View article: Adolescents and young adults with germline <i>CDH1</i> variants and the risk of overtreatment
Adolescents and young adults with germline <i>CDH1</i> variants and the risk of overtreatment Open
Background Adolescents and young adults (AYA) with germline CDH1 variants are at risk of overtreatment when precancer lesions are detected with endoscopic screening. We characterize diffuse-type gastric cancer prevalence and survival in AY…
View article: Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria
Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria Open
Chronic spontaneous urticaria (CSU) is an inflammatory disorder that manifests with hives, angioedema, or both and lasts more than or equal to 6 weeks. Although certain elements of CSU pathogenesis are well defined, others remain unclear. …
View article: 259 Eighty-six-fold increase in HIV diagnosis with “Opt-out” Screening: Frontlines of Communities in the U.S. (FOCUS) Program in the UHealth Tower (UHT) Emergency Department (ED) - path to eliminate HIV transmission in the U.S.
259 Eighty-six-fold increase in HIV diagnosis with “Opt-out” Screening: Frontlines of Communities in the U.S. (FOCUS) Program in the UHealth Tower (UHT) Emergency Department (ED) - path to eliminate HIV transmission in the U.S. Open
OBJECTIVES/GOALS: Early HIV detection and treatment are key to reducing patient morbidity and mortality, yet 40% of people living with HIV do not know their status. “OPT-OUT” approaches to hiv testing, in which patients #_MSOCOM_1 are info…
View article: Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria
Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria Open
Most clinicians favored omalizumab over other potential treatments due to safety. Although younger clinicians were more likely to prescribe omalizumab, cost and formulary access were major barriers. Only 22% of respondents reported 80% or …
View article: Anaphylaxis: A 2023 practice parameter update
Anaphylaxis: A 2023 practice parameter update Open
This practice parameter update focuses on 7 areas in which there are new evidence and new recommendations. Diagnostic criteria for anaphylaxis have been revised, and patterns of anaphylaxis are defined. Measurement of serum tryptase is imp…
View article: International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023 Open
Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐A…
View article: Anaphylaxis to vaccinations: A review of the literature and evaluation of the COVID-19 mRNA vaccinations
Anaphylaxis to vaccinations: A review of the literature and evaluation of the COVID-19 mRNA vaccinations Open
Recent reports of allergic reactions to the Pfizer-BioNTech and the Moderna COVID-19 vaccines have resulted in questions about how and to whom they can be safely administered. Although anaphylaxis was not observed in clinical trials for ei…
View article: Digital Health Technology in Asthma: A Comprehensive Scoping Review
Digital Health Technology in Asthma: A Comprehensive Scoping Review Open
Digital health interventions show substantial promise for asthma disease monitoring and personalization of treatment. To be successful, future interventions will need to include both inhaler device and software elements, combining accurate…